499 related articles for article (PubMed ID: 28374901)
1. The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease.
Ferstl PG; Filmann N; Brandt C; Zeuzem S; Hogardt M; Kempf VAJ; Müller M; Waidmann O; Reinheimer C
Liver Int; 2017 Oct; 37(10):1488-1496. PubMed ID: 28374901
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center.
Huang YC; Wu PF; Lin YT; Wang FD
J Microbiol Immunol Infect; 2019 Apr; 52(2):304-311. PubMed ID: 30097388
[TBL] [Abstract][Full Text] [Related]
3. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
[TBL] [Abstract][Full Text] [Related]
4. Predicting acquisition of carbapenem-resistant Gram-negative pathogens in intensive care units.
Dantas LF; Dalmas B; Andrade RM; Hamacher S; Bozza FA
J Hosp Infect; 2019 Oct; 103(2):121-127. PubMed ID: 31039381
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Bassetti M; Echols R; Matsunaga Y; Ariyasu M; Doi Y; Ferrer R; Lodise TP; Naas T; Niki Y; Paterson DL; Portsmouth S; Torre-Cisneros J; Toyoizumi K; Wunderink RG; Nagata TD
Lancet Infect Dis; 2021 Feb; 21(2):226-240. PubMed ID: 33058795
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria.
Nordmann P; Poirel L
Clin Infect Dis; 2019 Nov; 69(Suppl 7):S521-S528. PubMed ID: 31724045
[TBL] [Abstract][Full Text] [Related]
8. Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study.
Lanini S; Costa AN; Puro V; Procaccio F; Grossi PA; Vespasiano F; Ricci A; Vesconi S; Ison MG; Carmeli Y; Ippolito G;
PLoS One; 2015; 10(4):e0123706. PubMed ID: 25835018
[TBL] [Abstract][Full Text] [Related]
9. Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia.
Micek ST; Welch EC; Khan J; Pervez M; Doherty JA; Reichley RM; Hoppe-Bauer J; Dunne WM; Kollef MH
J Hosp Med; 2011 Sep; 6(7):405-10. PubMed ID: 21916003
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
Karaaslan A; Soysal A; Altinkanat Gelmez G; Kepenekli Kadayifci E; Söyletir G; Bakir M
J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
[TBL] [Abstract][Full Text] [Related]
11. Clinico-microbiological profile and outcomes of nosocomial sepsis in an Indian tertiary care hospital--a prospective cohort study.
Saravu K; Prasad M; Eshwara VK; Mukhopadhyay C
Pathog Glob Health; 2015 Jul; 109(5):228-35. PubMed ID: 26184918
[TBL] [Abstract][Full Text] [Related]
12. Attributable mortality from extensively drug-resistant gram-negative infections using propensity-matched tracer antibiotic algorithms.
Kadri SS; Strich JR; Swihart BJ; Hohmann S; Dekker JP; Palmore T; Bonne S; Freeman B; Raybould J; Shah NG; Patel D; Husson J; Jacobs MD; Duong L; Follmann D; Hooper DC; Timpone J; Danner RL
Am J Infect Control; 2019 Sep; 47(9):1040-1047. PubMed ID: 30824387
[TBL] [Abstract][Full Text] [Related]
13. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
Shah PG; Shah SR
J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals.
Papst L; Beović B; Pulcini C; Durante-Mangoni E; Rodríguez-Baño J; Kaye KS; Daikos GL; Raka L; Paul M;
Clin Microbiol Infect; 2018 Oct; 24(10):1070-1076. PubMed ID: 29410094
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological characteristics and antimicrobial susceptibility among carbapenem-resistant non-fermenting bacteria in Brazil.
Dias VC; Diniz CG; Peter AC; Bastos AN; Bastos VQ; Bastos LQ; Da Silva VL
J Infect Dev Ctries; 2016 Jun; 10(6):544-53. PubMed ID: 27367001
[TBL] [Abstract][Full Text] [Related]
16. Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study.
Siwakoti S; Subedi A; Sharma A; Baral R; Bhattarai NR; Khanal B
Antimicrob Resist Infect Control; 2018; 7():114. PubMed ID: 30275945
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant gram-negative bacterial infections after liver transplantation - spectrum and risk factors.
Zhong L; Men TY; Li H; Peng ZH; Gu Y; Ding X; Xing TH; Fan JW
J Infect; 2012 Mar; 64(3):299-310. PubMed ID: 22198738
[TBL] [Abstract][Full Text] [Related]
18. Effect of short-term carbapenem restriction on the incidence of non-pseudomonal multi-drug resistant Gram-negative bacilli in an intensive care unit.
Abdallah M; Badawi M; Alzaagi I; Issa KN; Rasheed A; Alharthy A
J Chemother; 2019 Sep; 31(5):261-266. PubMed ID: 30983552
[TBL] [Abstract][Full Text] [Related]
19. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
20. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
